UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040689
Receipt number R000046349
Scientific Title Glycemic control among diabetic patients complicated with sarcopenia and frailty.
Date of disclosure of the study information 2020/06/10
Last modified on 2023/03/02 18:05:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Glycemic control among diabetic patients complicated with sarcopenia and frailty.

Acronym

Glycemic control among diabetic patients complicated with sarcopenia and frailty.

Scientific Title

Glycemic control among diabetic patients complicated with sarcopenia and frailty.

Scientific Title:Acronym

Glycemic control among diabetic patients complicated with sarcopenia and frailty.

Region

Japan


Condition

Condition

diabetes mellitus

Classification by specialty

Endocrinology and Metabolism Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To elucidate the relation between complication with sarcopenia-frailty, insulin resistance, clinical course after education, compliance/adherence to therapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

BMI, skeletal muscle mass index (SMI), HgbA1c, serum CPR, CPI

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

education for diabetic patients

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Diabetic patients who are admitted for diabetic education and going to have physiotherapy.

Key exclusion criteria

Severe cardio-pulmonary disease
Severe Hypertension
Fever
Recent pulmonary infarction,
Severe liver dysfunction
Severe renal dysfunction
Severe Orthopedics problems
Severe metabolic disease
Cardiac pacemaker or elctronic implant
Clipping, metal in the body
Weight over 200kgs

Target sample size

140


Research contact person

Name of lead principal investigator

1st name Tomokazu
Middle name
Last name Takakura

Organization

Juntendo University, Juntendo Tokyo Koto Geriatric Medical Center

Division name

Rehabilitation Medicine

Zip code

136-0075

Address

3-3-20 Shinsuna, Koto-ku, Tokyo, Japan

TEL

03-5632-3111

Email

t-takakura@juntendo.ac.jp


Public contact

Name of contact person

1st name Tomokazu
Middle name
Last name Takakura

Organization

Juntendo University, Juntendo Tokyo Koto Geriatric Medical Center

Division name

Rehabilitation Medicine

Zip code

136-0075

Address

3-3-20 Shinsuna, Koto-ku, Tokyo, Japan

TEL

03-5632-3111

Homepage URL


Email

t-takakura@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University, Juntendo Tokyo Koto Geriatric Medical Center

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University, Juntendo Tokyo Koto Geriatric Medical Center

Address

3-3-20 Shinsuna, Koto-ku, Tokyo, Japan

Tel

03-5632-3111

Email

kubota_kei@juntendo.gmc.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 05 Month 25 Day

Date of IRB

2020 Year 06 Month 02 Day

Anticipated trial start date

2020 Year 06 Month 11 Day

Last follow-up date

2022 Year 05 Month 31 Day

Date of closure to data entry

2022 Year 05 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 06 Month 08 Day

Last modified on

2023 Year 03 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046349


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name